UNSPSC 51302102: Triafungin

This classification denotes an antifungal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E51A927SNR. European Medicines Agency schedules Triafungin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11250MIG. Triafungin generally arises in the molecular formula C13H10N4. The term TRIAFUNGIN is an International Non-Proprietary Name or INN. TRIAFUNGIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule triafungin under HS 29339990 and SITC 51577. As of Q4 2014, TRIAFUNGIN remains the US FDA Preferred Term for this commodity. Triafungin bears US NLM identifiers UMLS ID C2348816 and NCI Concept Code C72965. SMILES: N1C(NNC2C1CNCC2)CC1CCCCC1.

UNSPSC 51302102 Triafungin is a Commodity code whose recent state and local activity does not align with its nominal scope. The two most recent opportunities tagged under this code involve liquid aluminum sulfate for wastewater treatment (City of Austin) and medical aid supplies for fire rescue (City of Tampa) — neither of which relates to triafungin, an antifungal pharmaceutical compound. State and local procurement databases occasionally apply misaligned codes to opportunities; this code shows little relevant recent activity grounded in its actual product definition.

The mismatch suggests the code either sees minimal state and local procurement demand or has been superseded by more specific commodity classifications in active sourcing. Firms evaluating pursuit under 51302102 should verify current code alignment with issuing bodies before investing in opportunity capture, as the recent record does not support a reliable pipeline of triafungin-related solicitations.